One such lawsuit is now before the courts (reported on by LawyersandSettlements here). That lawsuit alleges Diep An developed bladder cancer after using Actos. An’s family filed the lawsuit claiming Takeda knew as early as 2005 about the link between Actos and bladder cancer, but delayed notifying the public or the medical community about that link.
Given that there are reportedly more than 3,000 lawsuits filed against Takeda regarding Actos, Takeda could be in for a long haul, similar to that of rival drugmaker GlaxoSmithKline, who faced lawsuits over its diabetes drug, Avandia. In 2010, Avandia was subject to severe limitations on its use following concerns that the drug was linked to serious heart problems. Those restrictions could be eased, following a meeting of an FDA advisory panel, but GlaxoSmithKline reportedly faced at least 10,000 lawsuits concerning its drug.
Whether Takeda faces that many Actos lawsuits remains to be seen, but at least two studies have suggested a link between the use of Actos and the development of bladder cancer. Meanwhile, in June 2011, the FDA issued an announcement that using Actos for more than a year could be associated with an increased risk of bladder cancer. At the same time, the agency noted the warning label would be updated to reflect that risk.
READ MORE ACTOS SIDE EFFECTS LEGAL NEWS
In a lawsuit filed by the family of Joseph Raymond against Takeda, plaintiffs claim that patients have the option of safer products, but because they were not adequately warned about the risks, used Actos. “As a result of Defendants’ actions, Joseph Raymond and his physician(s) were unaware, and could not have reasonably known or have learned through reasonable diligence, that Joseph Raymond had been exposed to the risks identified in this Complaint, and that those risks were the direct and proximate result of Defendants’ conduct,” the lawsuit states.
The Raymond lawsuit is In Re: Actos Product Liability Litigation, Case 6:12-cv-02055, District Court, Western District of Louisiana.